<DOC>
	<DOC>NCT00425685</DOC>
	<brief_summary>ECMO offers an acceptable cardiopulmonary support in adults with similar hospital survival rates as other mechanical support. It is versatile and salvages some patients, who may otherwise die. Improvement in intermediate term outcome will require multidisciplinary approach to protect organ function and limit organ injury during this support.</brief_summary>
	<brief_title>Use of ECMO in Acute MI</brief_title>
	<detailed_description>Extracorporeal membrane oxygenation (ECMO) is an established treatment option in patients with Cardiogenic Schock. We retrospectively reviewed early and mid-term outcome as well as predictors of survival during using ECMO. This report reviews our experience with this support system in last 3 years.</detailed_description>
	<criteria>Acute MI Contraindication against ECMO</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.</keyword>
</DOC>